Skip to main content
Clinical Trials/NL-OMON34545
NL-OMON34545
Recruiting
Not Applicable

Drug-Eluting Balloon vs Conventional Balloon Pre-dilatation: An Open Randomized Trial in Acute Myocardial Infarction safety and efficacy of the Genous Bio-engineered R Stent* pre-dilated with paclitaxel-eluting balloon (Pantera®) versus the Genous Bio-engineered R Stent* pre-dilated with non drug eluting balloon in Patients undergoing PCI for ST-segment Elevation Myocardial Infarction - DEBORA2

Diagram B.V.0 sites128 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
Diagram B.V.
Enrollment
128
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
Diagram B.V.

Eligibility Criteria

Inclusion Criteria

  • Males or females \>\= 18 years of age and \<\= 80 years with symptoms of AMI of more than 30 minutes but less than 24 hours
  • ST segment elevation of \> 1 mV in 2 adjacent ECG leads, with cumulative ST segment deviation of 6 mm or more

Exclusion Criteria

  • Women of child\-bearing potential
  • Severe hepatic or renal disease
  • Previous participation in the study
  • Life expectancy of \< 1 year
  • Factors making follow\-up difficult
  • AMI pre\-treated with thrombolysis
  • Patients who have previously received murine therapeutic antibodies and exhibited sensitization through the production of Human Anti\-Murine Antibodies (HAMA)
  • Known sensitivity to aspirin, clopidogrel, or coumadin
  • Patients in whom anti\-platelet and/or anticoagulant therapy is contraindicated
  • Unable to provide informed consent

Outcomes

Primary Outcomes

Not specified

Similar Trials